MedPath

THE GEORGE INSTITUTE

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)

Phase 3
Completed
Conditions
Ischemic Stroke
High Blood Pressure
Interventions
Drug: Low-dose rtPA
Drug: Standard-dose rtPA
Other: Intensive blood pressure (BP) lowering
Other: BP management policies
First Posted Date
2011-08-24
Last Posted Date
2021-10-13
Lead Sponsor
The George Institute
Target Recruit Count
4587
Registration Number
NCT01422616
Locations
🇦🇺

Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

Completed
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2009-07-30
Last Posted Date
2014-05-19
Lead Sponsor
The George Institute
Target Recruit Count
8494
Registration Number
NCT00949286
Locations
🇦🇺

LCC 80 - Canberra Hospital, Garran, Australian Capital Territory, Australia

🇦🇺

LCC 28 - Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

🇦🇺

LCC 48 - Gosford, Gosford, New South Wales, Australia

and more 169 locations

Crystalloid Versus Hydroxyethyl Starch Trials

Phase 3
Completed
Conditions
Intensive Care
Interventions
Drug: 6% Hydroxy-ethyl starch (130/0.4)
Drug: Saline
First Posted Date
2009-07-08
Last Posted Date
2012-11-16
Lead Sponsor
The George Institute
Target Recruit Count
7000
Registration Number
NCT00935168
Locations
🇦🇺

The George Institute for International Health, Sydney, New South Wales, Australia

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

Not Applicable
Completed
Conditions
Hypertension
Stroke
Intracerebral Hemorrhage
First Posted Date
2008-07-16
Last Posted Date
2013-12-13
Lead Sponsor
The George Institute
Target Recruit Count
2839
Registration Number
NCT00716079
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇦🇷

Regional Coordinating Centre Argentina, Buenos Aires, Argentina

🇦🇺

Canberra Hospital, Canberra, Australian Capital Territory, Australia

and more 59 locations

A Clinical Trial of IntensiVE Dialysis

Phase 4
Completed
Conditions
Uremia
Renal Replacement Therapy
Renal Dialysis
End Stage Renal Disease
End Stage Kidney Disease
First Posted Date
2008-04-01
Last Posted Date
2019-12-03
Lead Sponsor
The George Institute
Target Recruit Count
200
Registration Number
NCT00649298
Locations
🇦🇺

The Canberra Hospital, Canberra, Australian Capital Territory, Australia

🇦🇺

RPAH/Concord, Sydney, New South Wales, Australia

🇦🇺

Sydney Adventist Hospital, Sydney, New South Wales, Australia

and more 37 locations

The Dietary Intervention in e-Shopping Trial

Not Applicable
Completed
Conditions
Behaviour
First Posted Date
2006-07-14
Last Posted Date
2006-07-14
Lead Sponsor
The George Institute
Target Recruit Count
500
Registration Number
NCT00352508
Locations
🇦🇺

The George Institute, Sydney, New South Wales, Australia

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

Phase 4
Completed
Conditions
Cerebrovascular Accidents
Diabetes Mellitus
Myocardial Infarction
Angina Pectoris
Interventions
Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin
Behavioral: Health Promotion
First Posted Date
2005-12-08
Last Posted Date
2018-09-12
Lead Sponsor
The George Institute
Target Recruit Count
3712
Registration Number
NCT00263393
Locations
🇮🇳

Byrraju Foundation Primary Healthcare Centres in rural West Godavari and East Godavari Dstricts, Bhimavaram, Andhra Pradesh, India

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Not Applicable
Completed
Conditions
CVA (Cerebrovascular Accident)
Cerebral Hemorrhage
Intracranial Hemorrhages
First Posted Date
2005-09-26
Last Posted Date
2008-06-26
Lead Sponsor
The George Institute
Target Recruit Count
404
Registration Number
NCT00226096
Locations
🇦🇺

Concord Hospital, Concord, New South Wales, Australia

🇦🇺

Gosford Hospital, Gosford, New South Wales, Australia

🇦🇺

St George Hospital, Kogarah, New South Wales, Australia

and more 16 locations

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

Phase 4
Completed
Conditions
Acute Renal Failure
First Posted Date
2005-09-22
Last Posted Date
2009-02-27
Lead Sponsor
The George Institute
Target Recruit Count
1508
Registration Number
NCT00221013
Locations
🇦🇺

The Austin Hopsital, Heidelberg, Victoria, Australia

Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health

Not Applicable
Completed
Conditions
Hypercholesterolemia
First Posted Date
2005-09-22
Last Posted Date
2009-02-13
Lead Sponsor
The George Institute
Target Recruit Count
3708
Registration Number
NCT00220974
Locations
🇦🇺

The George Institute for International Health, Camperdown, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath